Liposomes embedded with PEGylated ultrasmall iron oxide nanoparticles integrate ferroptosis activation, MRI tracing, and pH/ROS-sensitive drug delivery for combination cancer therapies.
breaking through a cell's outer lipid layer as the cell dies. New research has shown that diPUFA phospholipids are a key driver of a form of cell death known as ferroptosis.
Understanding the relationship between ferroptosis, reactive oxygen species (ROS), and lipid metabolism is crucial. Nanomaterials offer precision and efficiency in delivering therapeutic agents to ...